Literature DB >> 6802353

Intravenous naloxone in acute respiratory failure.

J Ayres, J Rees, T Lee, G M Cochrane.   

Abstract

A 58-year-old man presented with acute on chronic respiratory failure. In the acute stage of his illness an infusion of the opiate antagonist naloxone caused an improvement in oxygen saturation as measured by ear oximetry from 74% to 85%, while a saline infusion resulted in a return of oxygen saturation to the original value. When he had recovered from the acute episode the same dose of naloxone had no effect on oxygen saturation. These findings suggest that in acute respiratory failure there may be overproduction of, or increased sensitivity to, endorphins.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6802353      PMCID: PMC1496525          DOI: 10.1136/bmj.284.6320.927

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  4 in total

1.  Respiratory control during hypoxia in newborn rabbits: implied action of endorphins.

Authors:  M M Grunstein; T A Hazinski; M A Schlueter
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1981-07

2.  Endorphins and the control of breathing. Ability of naloxone to restore flow-resistive load compensation in chronic obstructive pulmonary disease.

Authors:  T V Santiago; C Remolina; V Scoles; N H Edelman
Journal:  N Engl J Med       Date:  1981-05-14       Impact factor: 91.245

3.  Endogenous opiates and chemical control of breathing in humans.

Authors:  J A Fleetham; H Clarke; S Dhingra; V Chernick; N R Anthonisen
Journal:  Am Rev Respir Dis       Date:  1980-06

4.  Diaphragm paralysis and ventilatory failure in chronic proximal spinal muscular atrophy.

Authors:  H Haas; L R Johnson; T H Gill; T S Armentrout
Journal:  Am Rev Respir Dis       Date:  1981-04
  4 in total
  2 in total

Review 1.  Naloxone: new therapeutic roles.

Authors:  B Milne; K Jhamandas
Journal:  Can Anaesth Soc J       Date:  1984-05

2.  Endorphins and exercise.

Authors:  V J Harber; J R Sutton
Journal:  Sports Med       Date:  1984 Mar-Apr       Impact factor: 11.136

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.